Medicare Enrolled
Dr. Kathryn Bower, D.O.
Hematology & Oncology · Bradenton, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bower from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bower?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bower
Dr. Kathryn Bower is a hematology & oncology specialist in Bradenton, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Bower performed 30,676 Medicare services across 1,250 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bower received a total of $16,164 from 93 pharmaceutical and/or device companies across 801 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bower is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 19% volume in FL
$16,164 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 12951 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗30,676
Medicare services
Top 19% in FL for hematology & oncology
1,250
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,556 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 13,500 | $1 | $2 |
| Epoetin alfa injection (Retacrit) for anemia | 5,780 | $6 | $16 |
| Denosumab injection (Prolia/Xgeva) | 2,400 | $17 | $45 |
| Iron infusion (Monoferric) | 2,300 | $17 | $43 |
| Dexamethasone injection (steroid) | 1,614 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 900 | $1 | $2 |
| Complete blood count (CBC) with differential | 893 | $8 | $16 |
| Injection of additional new drug or substance into vein | 520 | $12 | $31 |
| Injection, cetirizine hydrochloride, 0.5 mg | 440 | $12 | $30 |
| Office visit, established patient (30-39 min) | 395 | $93 | $256 |
| Office visit, established patient, complex (40-54 min) | 314 | $134 | $363 |
| Administration of chemotherapy into vein, 1 hour or less | 263 | $99 | $267 |
| Drug injection, under skin or into muscle | 230 | $11 | $28 |
| Office visit, established patient (20-29 min) | 193 | $68 | $182 |
| Injection, diphenhydramine hcl, up to 50 mg | 185 | $1 | $2 |
| Administration of chemotherapy into vein, each additional hour | 166 | $22 | $57 |
| Administration of additional new drug or substance into vein, 1 hour or less | 90 | $49 | $130 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 81 | $49 | $132 |
| Hospital follow-up visit, high complexity | 63 | $94 | $238 |
| Infusion into a vein for hydration, each additional hour | 55 | $10 | $25 |
| New patient office visit, complex (60-74 min) | 55 | $160 | $447 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | 55 | $116 | $333 |
| Irrigation of implanted venous access drug delivery device | 42 | $18 | $52 |
| Infusion, normal saline solution , 1000 cc | 41 | $2 | $5 |
| New patient office visit (45-59 min) | 39 | $126 | $338 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 34 | $55 | $149 |
| Infusion into a vein for hydration, 31-60 minutes | 28 | $25 | $67 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
52.2% high complexity
40.9% medium
7.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,164
Total received (2018-2024)
Avg $2,309/year across 7 years
Top 29% in FL for hematology & oncology
93
Companies
801
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,612 (96.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$552 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,488
2023
$4,002
2022
$3,625
2021
$2,697
2020
$1,168
2019
$100
2018
$85
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,398
AstraZeneca Pharmaceuticals LP
$807
Incyte Corporation
$782
Janssen Biotech, Inc.
$779
PFIZER INC.
$745
Daiichi Sankyo Inc.
$655
Merck Sharp & Dohme LLC
$563
Takeda Pharmaceuticals U.S.A., Inc.
$532
Lilly USA, LLC
$510
Gilead Sciences, Inc.
$433
Eisai Inc.
$423
Seagen Inc.
$382
GlaxoSmithKline, LLC.
$378
E.R. Squibb & Sons, L.L.C.
$372
Genentech USA, Inc.
$354
BeiGene USA, Inc.
$345
Celgene Corporation
$323
SOBI, INC
$266
Rigel Pharmaceuticals, Inc.
$259
Boehringer Ingelheim Pharmaceuticals, Inc.
$236
Foundation Medicine, Inc.
$230
GENZYME CORPORATION
$212
ARRAY BIOPHARMA INC
$212
Regeneron Healthcare Solutions, Inc.
$205
ABBVIE INC.
$197
AVEO Pharmaceuticals, Inc.
$189
Astellas Pharma US Inc
$183
Merck Sharp & Dohme Corporation
$181
Aveo Pharmaceuticals, Inc.
$172
Karyopharm Therapeutics Inc.
$166
JAZZ PHARMACEUTICALS INC.
$165
PUMA BIOTECHNOLOGY, INC.
$145
Kite Pharma, Inc.
$145
AbbVie Inc.
$126
Dova Pharmaceuticals
$123
EISAI INC.
$119
EMD Serono, Inc.
$115
Bayer HealthCare Pharmaceuticals Inc.
$115
Exelixis Inc.
$113
Pharmacosmos Therapeutics Inc.
$107
Bayer Healthcare Pharmaceuticals Inc.
$104
SERVIER PHARMACEUTICALS LLC
$103
Myovant Sciences Inc.
$102
Agios Pharmaceuticals, Inc.
$98
Myriad Genetic Laboratories, Inc.
$94
Servier Pharmaceuticals LLC
$93
Sun Pharmaceutical Industries Inc.
$92
Sobi, Inc
$84
Immunomedics, Inc.
$77
Stemline Therapeutics Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$67
Amneal Pharmaceuticals LLC
$64
Global Blood Therapeutics, Inc.
$63
Sumitomo Pharma America, Inc.
$62
Mirati Therapeutics, Inc.
$62
CTI BioPharma Corp.
$59
TAIHO ONCOLOGY, INC.
$55
Fennec Pharmaceuticals, Inc.
$50
AMAG Pharmaceuticals, Inc.
$49
Celltrion USA Inc.
$47
GE HealthCare
$46
Genmab U.S., Inc.
$46
Pharmacyclics LLC, an AbbVie Company
$46
Kyowa Kirin, Inc.
$44
G1 Therapeutics, Inc.
$41
PharmaEssentia USA Corporation
$41
TOLMAR Pharmaceuticals, Inc.
$41
Apellis Pharmaceuticals, Inc.
$39
Acrotech Biopharma Inc.
$38
MorphoSys, US Inc.
$35
ADC Therapeutics America, Inc.
$35
MENARINI SILICON BIOSYSTEMS, INC.
$33
Epizyme, Inc.,
$32
Coherus Biosciences Inc.
$30
Deciphera Pharmaceuticals Inc.
$30
Puma Biotechnology, Inc.
$25
Azurity Pharmaceuticals, Inc.
$23
Spectrum Pharmaceuticals Inc.
$23
Blue Earth Diagnostics Limited
$22
Epizyme, Inc.
$21
Tactile Systems Technology Inc
$20
Telix Pharmaceuticals
$20
TerSera Therapeutics LLC
$19
BOSTON SCIENTIFIC CORPORATION
$18
Acrotech Biopharma LLC
$17
Tempus AI, Inc
$17
Organon LLC
$16
ACCORD HEALTHCARE, INC.
$16
Alnylam Pharmaceuticals Inc.
$15
SANOFI-AVENTIS U.S. LLC
$14
MAYNE PHARMA INC.
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
Jazz Pharmaceuticals Inc.
$12
Top 3 companies account for 18.5% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AVASTIN · Alecensa · Aliqopa · Axumin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erivedge · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Flexitouch Plus · GAZYVA · GILOTRIF · HEMADY · IBRANCE · ICLUSIG · ILLUCCIX · ILUMYA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · Monoferric · NERLYNX · NINLARO · Nubeqa · OJJAARA · ONCASPAR · ONPATTRO · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Phesgo · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYZNEUTA · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VONVENDI · Venclexta · Vonjo · WATCHMAN · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $53 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
21
Per 100K population
5.0
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bower is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bower experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Bower performed 13,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bower receive payments from pharmaceutical companies?
Yes. Dr. Bower received a total of $16,164 from 93 companies across 801 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bower's costs compare to other hematology & oncology specialists in Bradenton?
Dr. Bower's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bower) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Bradenton
Browse hematology & oncology specialists in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology